这是一篇来自已证抗体库的有关人类 CD10的综述,是根据128篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD10 抗体。
CD10 同义词: CALLA; CD10; CMT2T; NEP; SCA43; SFE

BioLegend
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (图 3a). Rheumatology (Oxford) (2020) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (图 s5). Nature (2019) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:33; 图 5b
BioLegend CD10抗体(Biolegend, 312214)被用于被用于流式细胞仪在人类样本上浓度为1:33 (图 5b). Nat Commun (2019) ncbi
小鼠 单克隆(HI10a)
  • mass cytometry; 人类; 图 s3a
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:20
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上浓度为1:20. Nature (2017) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 3
BioLegend CD10抗体(BioLegend/BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 e7a
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (图 e7a). Nature (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 1
BioLegend CD10抗体(Biolegend, 312214)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; African green monkey; 图 s1
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在African green monkey样本上 (图 s1). J Med Primatol (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:10; 图 s2g
BioLegend CD10抗体(Biolegend, HI10a)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 s2g). Nat Med (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 1
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (图 2a). Arthritis Rheumatol (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD10抗体(Biolegend, 312206)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HI10a)
  • 免疫细胞化学; 人类; 图 6
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于免疫细胞化学在人类样本上 (图 6). Oncogene (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:100
BioLegend CD10抗体(Biolegend, HI10a)被用于被用于流式细胞仪在人类样本上浓度为1:100. J Immunol Methods (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:100
BioLegend CD10抗体(BioLegend, 312210)被用于被用于流式细胞仪在人类样本上浓度为1:100. Front Cell Dev Biol (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 2
BioLegend CD10抗体(BioLegend, HI10a)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 1
BioLegend CD10抗体(Biolegend, HI10a)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 ev4b
赛默飞世尔 CD10抗体(Invitrogen, PA5-29354)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 ev4b). EMBO Rep (2020) ncbi
小鼠 单克隆(eBioCB-CALLA (CB-CALLA))
  • 流式细胞仪; 人类; 图 7
赛默飞世尔 CD10抗体(ebioscience, CB-CALLA)被用于被用于流式细胞仪在人类样本上 (图 7). J Immunol (2017) ncbi
小鼠 单克隆(2A1H5E1)
  • 免疫组化-石蜡切片; 人类; 图 5a
赛默飞世尔 CD10抗体(Thermo Fisher, 2A1H5E1)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5a). World J Gastroenterol (2016) ncbi
小鼠 单克隆(SN5c)
  • 流式细胞仪; 人类; 1:5
赛默飞世尔 CD10抗体(eBioscience, SN5c)被用于被用于流式细胞仪在人类样本上浓度为1:5. Nat Commun (2016) ncbi
小鼠 单克隆(eBioCB-CALLA (CB-CALLA))
  • 流式细胞仪; 人类; 图 st9
赛默飞世尔 CD10抗体(eBioscience, CB-CALLA)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:10; 图 3a
赛默飞世尔 CD10抗体(Thermo Scientific, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10 (图 3a). Virchows Arch (2016) ncbi
小鼠 单克隆(eBioCB-CALLA (CB-CALLA))
  • 流式细胞仪; 小鼠
赛默飞世尔 CD10抗体(eBioscience, eBioCB-CALLA)被用于被用于流式细胞仪在小鼠样本上. Nat Chem Biol (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化; 人类; 1:50; 表 1
赛默飞世尔 CD10抗体(Neomarker, 56C6)被用于被用于免疫组化在人类样本上浓度为1:50 (表 1). Gut Liver (2016) ncbi
小鼠 单克隆(eBioCB-CALLA (CB-CALLA))
  • 流式细胞仪; 人类
赛默飞世尔 CD10抗体(e-bioscience, CB-CALLA)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(SN5c)
  • 流式细胞仪; 人类; 表 4
赛默飞世尔 CD10抗体(eBioscience, SN5c)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类
赛默飞世尔 CD10抗体(Caltag, MEM-78)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:20; 图 s5
赛默飞世尔 CD10抗体(Thermo Scientific, MS-728-S0)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20 (图 s5). Nat Commun (2015) ncbi
小鼠 单克隆(eBioCB-CALLA (CB-CALLA))
  • 流式细胞仪; 人类
赛默飞世尔 CD10抗体(eBioscience, CB-CALLA)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化; 人类; 1:200
赛默飞世尔 CD10抗体(Labvision, 56C6)被用于被用于免疫组化在人类样本上浓度为1:200. Leuk Res (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔 CD10抗体(Lavision, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Int J Hematol (2015) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类
赛默飞世尔 CD10抗体(Caltag, MEM 78)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD10抗体(Caltag, clone MEM 78)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD10抗体(Invitrogen, MEM-78)被用于被用于流式细胞仪在人类样本上 (图 1). EMBO J (2012) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD10抗体(Caltag, MEM-78)被用于被用于流式细胞仪在人类样本上 (图 4). Placenta (2011) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:10; 图 1, 2, 3
  • 免疫组化; 人类; 1:10
赛默飞世尔 CD10抗体(Neomarkers, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10 (图 1, 2, 3) 和 被用于免疫组化在人类样本上浓度为1:10. Am J Surg Pathol (2010) ncbi
小鼠 单克隆(MEM-78)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD10抗体(Invitrogen, MEM-78)被用于被用于流式细胞仪在人类样本上 (图 1). Bone Marrow Transplant (2011) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:20
赛默飞世尔 CD10抗体(Neomarkers, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20. Int J Surg Pathol (2007) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(56C6)
  • 免疫印迹; 小鼠; 1:1000; 图 5g
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, ab951)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5g). Acta Neuropathol Commun (2020) ncbi
domestic rabbit 单克隆(EPR2997)
  • 免疫印迹; 小鼠; 图 3e
艾博抗(上海)贸易有限公司 CD10抗体(abcam, ab79423)被用于被用于免疫印迹在小鼠样本上 (图 3e). Acta Neuropathol Commun (2018) ncbi
小鼠 单克隆(56C6)
  • 免疫印迹; 小鼠; 图 6
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, Ab951)被用于被用于免疫印迹在小鼠样本上 (图 6). Sci Rep (2016) ncbi
小鼠 单克隆(56C6)
  • 免疫印迹; 人类; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, ab951)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Stem Cells Int (2016) ncbi
domestic rabbit 单克隆(EPR2997)
  • 免疫印迹; 人类; 图 s2
艾博抗(上海)贸易有限公司 CD10抗体(Epitomics, 2569-1)被用于被用于免疫印迹在人类样本上 (图 s2). Nat Commun (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫印迹; 小鼠; 图 5
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, Ab951)被用于被用于免疫印迹在小鼠样本上 (图 5). Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫印迹; 小鼠; 1:1000
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, ab951)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Neurobiol Aging (2014) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 表 1
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, ab951)被用于被用于免疫组化-石蜡切片在人类样本上 (表 1), 被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Cell Death Dis (2013) ncbi
小鼠 单克隆(56C6)
  • 免疫印迹; 小鼠; 1:1000
艾博抗(上海)贸易有限公司 CD10抗体(Abcam, ab951)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Transl Psychiatry (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(F-4)
  • 免疫印迹; 小鼠; 1:1000; 图 s3c
圣克鲁斯生物技术 CD10抗体(Santa Cruz Biotechnology, sc-46656)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s3c). J Clin Invest (2019) ncbi
小鼠 单克隆(FR4D11)
  • 免疫细胞化学; 人类; 图 S1B
圣克鲁斯生物技术 CD10抗体(Santa cruz, FR4D11)被用于被用于免疫细胞化学在人类样本上 (图 S1B). Oncotarget (2016) ncbi
小鼠 单克隆(F-4)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术 CD10抗体(Santa Cruz, sc-46656)被用于被用于免疫细胞化学在人类样本上. Adv Healthc Mater (2015) ncbi
小鼠 单克隆(F-4)
  • 免疫印迹; 小鼠; 1:500; 图 3
圣克鲁斯生物技术 CD10抗体(Santa Cruz, sc-46656)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3). J Alzheimers Dis (2014) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3b
安迪生物R&D CD10抗体(R&D System, AF1126)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3b). Alzheimers Res Ther (2020) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 4h
安迪生物R&D CD10抗体(R&D Systems, AF1126)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4h). EMBO Mol Med (2019) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 6t
安迪生物R&D CD10抗体(R&D Systems, AF1126)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6t). J Exp Med (2018) ncbi
小鼠 单克隆(715820)
  • 免疫印迹; 人类; 图 4
安迪生物R&D CD10抗体(R&D, MAB11821)被用于被用于免疫印迹在人类样本上 (图 4). Sci Rep (2016) ncbi
大鼠 单克隆(200103)
  • 免疫印迹; 小鼠; 1:500; 图 6
安迪生物R&D CD10抗体(R&D, MAB1126)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6). Sci Rep (2016) ncbi
西格玛奥德里奇
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2
西格玛奥德里奇 CD10抗体(Roche Diagnostics, 790-4506)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 2). Oncol Lett (2016) ncbi
  • 免疫组化; 人类
西格玛奥德里奇 CD10抗体(Roche, 790-4506)被用于被用于免疫组化在人类样本上. J Hematol Oncol (2015) ncbi
  • 免疫组化; 人类
西格玛奥德里奇 CD10抗体(Ventana, 790-4506)被用于被用于免疫组化在人类样本上. Histopathology (2015) ncbi
美天旎
人类 单克隆(REA877)
  • 流式细胞仪; 人类; 图 3d
美天旎 CD10抗体(Miltenyi Biotec, REA877)被用于被用于流式细胞仪在人类样本上 (图 3d). N Biotechnol (2018) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(SN5c)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司 CD10抗体(AbD Serotech, MCA1556)被用于被用于流式细胞仪在人类样本上. Breast Cancer Res (2017) ncbi
小鼠 单克隆(SN5c)
  • 流式细胞仪; 人类; 表 3
伯乐(Bio-Rad)公司 CD10抗体(Serotec, SB5c)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 图 4e
丹科医疗器械技术服务(上海)有限公司 CD10抗体(DAKO, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4e). PLoS ONE (2020) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50; 表 3
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 3). Pathol Res Pract (2017) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 表 2
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上 (表 2). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, M7308)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Oncol Lett (2016) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50-1:100; 图 2
丹科医疗器械技术服务(上海)有限公司 CD10抗体(DAKO, M7308)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50-1:100 (图 2). Endocrinology (2016) ncbi
小鼠 单克隆(56C6)
  • 免疫组化-冰冻切片; 人类; 1:20; 图 4
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, clone: 56C6)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:20 (图 4). J Immunol Res (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化; 人类; 1:100; 图 2
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, CD56C6)被用于被用于免疫组化在人类样本上浓度为1:100 (图 2). Int J Gynecol Pathol (2015) ncbi
小鼠 单克隆(56C6)
  • 免疫组化; 人类; 图 1
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, 56C6)被用于被用于免疫组化在人类样本上 (图 1). Cancer Genet (2013) ncbi
小鼠 单克隆(56C6)
  • 免疫组化; 人类; 1:25
丹科医疗器械技术服务(上海)有限公司 CD10抗体(Dako, M7308)被用于被用于免疫组化在人类样本上浓度为1:25. Blood Cancer J (2013) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(ALB1)
  • 流式细胞仪; 人类; 图 s7c
贝克曼库尔特实验系统(苏州)有限公司 CD10抗体(Beckman Coulter, IM3633)被用于被用于流式细胞仪在人类样本上 (图 s7c). Cell (2017) ncbi
小鼠 单克隆(ALB1)
  • 流式细胞仪; 人类; 1:25; 图 1b
贝克曼库尔特实验系统(苏州)有限公司 CD10抗体(Beckman Coulter, ALB1)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1b). Cell Transplant (2017) ncbi
小鼠 单克隆(J5)
  • 流式细胞仪; 人类; 表 1
贝克曼库尔特实验系统(苏州)有限公司 CD10抗体(Beckman Coulter, J5)被用于被用于流式细胞仪在人类样本上 (表 1). Int J Lab Hematol (2016) ncbi
小鼠 单克隆(ALB1)
  • 流式细胞仪; 人类; 表 1
贝克曼库尔特实验系统(苏州)有限公司 CD10抗体(Beckman Coulter, ALB1)被用于被用于流式细胞仪在人类样本上 (表 1). Int J Lab Hematol (2016) ncbi
小鼠 单克隆(ALB1)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD10抗体(Beckman Coulter, ALB1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
Menarini
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:10; 表 2
Menarini CD10抗体(Menarini, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10 (表 2). Histopathology (2017) ncbi
徕卡显微系统(上海)贸易有限公司
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2c
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, NCL-L-CD10-270)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2c). BMC Cancer (2020) ncbi
单克隆(56C6)
  • 免疫组化; 人类; 1:50; 图 2i
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化在人类样本上浓度为1:50 (图 2i). Diagn Pathol (2019) ncbi
  • 免疫组化-石蜡切片; 人类; 图 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, CD10-270-L-CE)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). J Clin Invest (2019) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 图 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, CD10-270-L-CE)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). J Clin Invest (2019) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:20; 图 i2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20 (图 i2). Am J Clin Pathol (2017) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 表 4
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica Microsystems, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上 (表 4). Ann Hematol (2017) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Hum Pathol (2017) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Mod Pathol (2017) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 图 2d
  • 免疫组化; 人类; 图 1d
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2d) 和 被用于免疫组化在人类样本上 (图 1d). Ann Diagn Pathol (2016) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 1:80; 图 2b
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, NCL-L-CD10-270)被用于被用于免疫组化在人类样本上浓度为1:80 (图 2b). Kaohsiung J Med Sci (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 表 1
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, Leica Biosystem, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上 (表 1). Cancer Sci (2016) ncbi
单克隆(56C6)
  • 免疫组化; 人类; 1:100; 图 1
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, 56C6)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1). Diagn Pathol (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 1
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 1). Rom J Morphol Embryol (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50; 表 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 2). Hum Pathol (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:20; 表 2
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20 (表 2). Am J Surg Pathol (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:10; 表 1
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10 (表 1). Pathol Res Pract (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:50; 图 3
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, NCL-L-CD10-270)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 3). Redox Biol (2015) ncbi
单克隆(56C6)
  • 免疫组化; 人类; 1:20
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化在人类样本上浓度为1:20. Virchows Arch (2015) ncbi
单克隆(56C6)
  • 免疫组化; 人类
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra Laboratories, 56C6)被用于被用于免疫组化在人类样本上. Int J Clin Exp Pathol (2015) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 3
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 3). Am J Surg Pathol (2015) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:150
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150. Genes Chromosomes Cancer (2015) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:1
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1. Cytopathology (2016) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra Laboratories, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上. Malays J Pathol (2014) ncbi
单克隆(56C6)
  • 免疫组化; 人类; 1:25
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica, 56C6)被用于被用于免疫组化在人类样本上浓度为1:25. Head Neck Pathol (2015) ncbi
单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 5
徕卡显微系统(上海)贸易有限公司 CD10抗体(Novocastra, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 5). PLoS ONE (2014) ncbi
单克隆(56C6)
  • 免疫组化; 人类; 1:10
徕卡显微系统(上海)贸易有限公司 CD10抗体(Leica Microsystems, 56C6)被用于被用于免疫组化在人类样本上浓度为1:10. Leukemia (2014) ncbi
碧迪BD
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 4s1
碧迪BD CD10抗体(BD Biosciences, 341092)被用于被用于流式细胞仪在人类样本上 (图 4s1). elife (2020) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 s3b
碧迪BD CD10抗体(BD Biosciences, 340923)被用于被用于流式细胞仪在人类样本上 (图 s3b). Nat Immunol (2018) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Lett (2018) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD10抗体(BD, cloneHI10a)被用于被用于流式细胞仪在人类样本上 (图 2b). Nat Med (2018) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 s3d
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 s3d). J Clin Invest (2017) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 4b
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 4b). Front Immunol (2017) ncbi
小鼠 单克隆(W8E7)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(Pharmingen, W8E7)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(Becton Dickinson, 555376)被用于被用于流式细胞仪在人类样本上. Stem Cell Reports (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上 (图 s1b). Sci Rep (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上 (图 1a). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 3d). Angiogenesis (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上. JCI Insight (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD10抗体(BD, 557143)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(BD Bioscience, 555375)被用于被用于流式细胞仪在人类样本上. Haematologica (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 3). BMC Musculoskelet Disord (2016) ncbi
小鼠 单克隆(HI10a)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 s1a, s1b, s1c
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 s1a, s1b, s1c). Science (2016) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (图 6). J Exp Med (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD10抗体(BD Biosciences, 555375)被用于被用于流式细胞仪在人类样本上 (图 2). J Endod (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD10抗体(BD, HI10a)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(W8E7)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD10抗体(BD Biosciences, W8E7)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 1:50
碧迪BD CD10抗体(BD, 340923)被用于被用于流式细胞仪在人类样本上浓度为1:50. Cell Stem Cell (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(BD Biosciences, 555376)被用于被用于流式细胞仪在人类样本上. Nat Commun (2015) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(BD Biosciences, 341092)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 小鼠; 图 s3
碧迪BD CD10抗体(Pharmingen, 557143)被用于被用于流式细胞仪在小鼠样本上 (图 s3). Stem Cell Res (2014) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类; 10 ul per test
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上浓度为10 ul per test. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HI10a)
  • 流式细胞仪; 人类
碧迪BD CD10抗体(BD Biosciences, HI10a)被用于被用于流式细胞仪在人类样本上. Immunology (2014) ncbi
Monosan
小鼠 单克隆(56C6)
  • 免疫组化-石蜡切片; 人类; 1:20; 图 1e
Monosan CD10抗体(Monosan, 56C6)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20 (图 1e). J Hematop (2016) ncbi
文章列表
  1. Lackie R, Marques Lopes J, Ostapchenko V, Good S, Choy W, van Oosten Hawle P, et al. Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2020;8:143 pubmed 出版商
  2. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed 出版商
  3. Gee M, Son S, Jeon S, Do J, Kim N, Ju Y, et al. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimers Res Ther. 2020;12:45 pubmed 出版商
  4. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed 出版商
  5. Maestre L, García García J, Jiménez S, Reyes García A, García González Á, Montes Moreno S, et al. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations. PLoS ONE. 2020;15:e0229743 pubmed 出版商
  6. Cho I, Lee H, Yoon S, Ryu K, Ko Y, Kim W, et al. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma. BMC Cancer. 2020;20:120 pubmed 出版商
  7. Eede P, Obst J, Benke E, Yvon Durocher G, Richard B, Gimber N, et al. Interleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer's disease-like mice. EMBO Rep. 2020;21:e48530 pubmed 出版商
  8. Nam A, Kim K, Chaligne R, Izzo F, Ang C, Taylor J, et al. Somatic mutations and cell identity linked by Genotyping of Transcriptomes. Nature. 2019;571:355-360 pubmed 出版商
  9. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed 出版商
  10. Oyama Y, Nishida H, Kusaba T, Kadowaki H, Arakane M, Okamoto K, et al. Colon adenoma and adenocarcinoma with clear cell components - two case reports. Diagn Pathol. 2019;14:37 pubmed 出版商
  11. Beckelman B, Yang W, Kasica N, Zimmermann H, Zhou X, Keene C, et al. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. J Clin Invest. 2019;129:820-833 pubmed 出版商
  12. Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model. EMBO Mol Med. 2019;11: pubmed 出版商
  13. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed 出版商
  14. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  15. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed 出版商
  16. Ziegler Waldkirch S, Marksteiner K, Stoll J, d Errico P, Friesen M, Eiler D, et al. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2018;6:44 pubmed 出版商
  17. Reichenbach N, Delekate A, Breithausen B, Keppler K, Poll S, Schulte T, et al. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model. J Exp Med. 2018;215:1649-1663 pubmed 出版商
  18. Rudolf Oliveira R, Auat M, Cardoso C, Santos Pirath I, Lange B, Pires Silva J, et al. Determination of normal expression patterns of CD86, CD210a, CD261, CD262, CD264, CD358, and CD361 in peripheral blood and bone marrow cells by flow cytometry. Immunol Lett. 2018;194:44-55 pubmed 出版商
  19. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed 出版商
  20. Kunder C, Roncador G, Advani R, Gualco G, Bacchi C, Sabile J, et al. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas. Am J Clin Pathol. 2017;148:465-476 pubmed 出版商
  21. Gaidt M, Ebert T, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171:1110-1124.e18 pubmed 出版商
  22. Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, et al. Clinicopathological features of primary splenic follicular lymphoma. Ann Hematol. 2017;96:2063-2070 pubmed 出版商
  23. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  24. Verdanet E, Dereure O, René C, Tempier A, Benammar Hafidi A, Gallo M, et al. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology. 2017;71:648-660 pubmed 出版商
  25. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  26. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  27. Sarper M, Allen M, Gomm J, Haywood L, Decock J, Thirkettle S, et al. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Res. 2017;19:33 pubmed 出版商
  28. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed 出版商
  29. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed 出版商
  30. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  31. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed 出版商
  32. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  33. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  34. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed 出版商
  35. Han G, Yu W, Chu J, Liu Y, Jiang Y, Li Y, et al. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. Pathol Res Pract. 2017;213:1-6 pubmed 出版商
  36. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed 出版商
  37. Islek A, Yilmaz A, Elpek G, Erin N. Childhood chronic gastritis and duodenitis: Role of altered sensory neuromediators. World J Gastroenterol. 2016;22:8349-8360 pubmed
  38. Muñoz López A, Romero Moya D, Prieto C, Ramos Mejia V, Agraz Doblas A, Varela I, et al. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency. Stem Cell Reports. 2016;7:602-618 pubmed 出版商
  39. Soon G, Ow G, Chan H, Ng S, Wang S. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases. Ann Diagn Pathol. 2016;24:40-6 pubmed 出版商
  40. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed 出版商
  41. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed 出版商
  42. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  43. Xu J, De Winter F, Farrokhi C, Rockenstein E, Mante M, Adame A, et al. Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model. Sci Rep. 2016;6:31692 pubmed 出版商
  44. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed 出版商
  45. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed 出版商
  46. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed 出版商
  47. Ugras N, Yerci O, Coşkun S, Ocakoglu G, Sarkut P, Dündar H. Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas. Kaohsiung J Med Sci. 2016;32:356-61 pubmed 出版商
  48. Chen P, Chen Z, Hou W, Yu L, Chen R. Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer's disease. Sci Rep. 2016;6:29760 pubmed 出版商
  49. Ahmed N, Murakami M, Hirose Y, Nakashima M. Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem Cells Int. 2016;2016:8102478 pubmed 出版商
  50. Takagi Y, Shimada K, Shimada S, Sakamoto A, Naoe T, Nakamura S, et al. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. Cancer Sci. 2016;107:1270-80 pubmed 出版商
  51. Sun J, Zhang B, Li L, Yu H, Wang B. Hepatoid adenocarcinoma of the lung without production of ?-fetoprotein: A case report and review of the literature. Oncol Lett. 2016;12:189-194 pubmed
  52. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed 出版商
  53. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  54. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed 出版商
  55. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  56. Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, et al. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer. Virchows Arch. 2016;469:191-201 pubmed 出版商
  57. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  58. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  59. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  60. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  61. Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96-102 pubmed 出版商
  62. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed 出版商
  63. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed 出版商
  64. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed 出版商
  65. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  66. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  67. van den Brand M, Balagué O, van Cleef P, Groenen P, Hebeda K, de Jong D, et al. A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma. J Hematop. 2016;9:3-8 pubmed
  68. Pilge H, Fröbel J, Mrotzek S, Fischer J, Prodinger P, Zilkens C, et al. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban. BMC Musculoskelet Disord. 2016;17:108 pubmed 出版商
  69. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  70. Somasundaram V, Soni S, Chopra A, Rai S, Mahapatra M, Kumar R, et al. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016;38:141-50 pubmed 出版商
  71. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  72. Böger C, Haag J, Egberts J, Röcken C. Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder. Pathol Res Pract. 2016;212:54-8 pubmed 出版商
  73. Wang J, Lu R, Yang J, Li H, He Z, Jing N, et al. TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production. Nat Commun. 2015;6:8876 pubmed 出版商
  74. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed 出版商
  75. Mori M, Ito F, Shi L, Wang Y, Ishida C, Hattori Y, et al. Ovarian endometriosis-associated stromal cells reveal persistently high affinity for iron. Redox Biol. 2015;6:578-586 pubmed 出版商
  76. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  77. Kolhatkar N, Brahmandam A, Thouvenel C, Becker Herman S, Jacobs H, Schwartz M, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015;212:1663-77 pubmed 出版商
  78. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed 出版商
  79. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed 出版商
  80. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  81. Kim Y, Lee S, Kim J, Sung I, Park H, Shim C, et al. Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms. Gut Liver. 2016;10:220-7 pubmed 出版商
  82. Tzankov A, Leu N, Muenst S, Juskevicius D, Klingbiel D, Mamot C, et al. Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study. J Hematol Oncol. 2015;8:70 pubmed 出版商
  83. Engel B, Constantinou P, Sablatura L, Doty N, Carson D, Farach Carson M, et al. Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. Adv Healthc Mater. 2015;4:1664-74 pubmed 出版商
  84. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed 出版商
  85. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed 出版商
  86. Petrov D, Pedrós I, Artiach G, Sureda F, Barroso E, Pallas M, et al. High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. Biochim Biophys Acta. 2015;1852:1687-99 pubmed 出版商
  87. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed 出版商
  88. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  89. Takata K, Noujima Harada M, Miyata Takata T, Ichimura K, Sato Y, Miyata T, et al. Clinicopathologic analysis of 6 lymphomatoid gastropathy cases: expanding the disease spectrum to CD4-CD8+ cases. Am J Surg Pathol. 2015;39:1259-66 pubmed 出版商
  90. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  91. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  92. Lee S, Koh Y, Roh H, Cha H, Kwon Y. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis. Genes Chromosomes Cancer. 2015;54:353-60 pubmed 出版商
  93. Rajnai H, Teleki I, Kiszner G, Meggyesházi N, Balla P, Vancsik T, et al. Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas. J Immunol Res. 2015;2015:528098 pubmed 出版商
  94. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed 出版商
  95. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed 出版商
  96. Laurenti E, Frelin C, Xie S, Ferrari R, Dunant C, Zandi S, et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell. 2015;16:302-13 pubmed 出版商
  97. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed 出版商
  98. Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, et al. Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015;6:6351 pubmed 出版商
  99. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed 出版商
  100. Kang Y, Cho C, Kwon S. Microcystic stromal tumor of the ovary with mutation in exon 3 of β-catenin: a case report. Int J Gynecol Pathol. 2015;34:121-5 pubmed 出版商
  101. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed 出版商
  102. Zinöcker S, Schindler C, Skinner J, Rogosch T, Waisberg M, Schickel J, et al. The V gene repertoires of classical and atypical memory B cells in malaria-susceptible West African children. J Immunol. 2015;194:929-39 pubmed 出版商
  103. Song M, Chung J, Lee G, Cho S, Hong J, Shin D, et al. Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era. Leuk Res. 2015;39:211-5 pubmed 出版商
  104. Song M, Chung J, Lee J, Yang D, Kim I, Shin D, et al. High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy. Int J Hematol. 2015;101:140-7 pubmed 出版商
  105. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  106. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  107. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed 出版商
  108. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed 出版商
  109. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  110. Kuroda N, Fujishima N, Hayes M, Moritani S, Ichihara S. Encapsulated papillary carcinoma, apocrine type, of the breast. Malays J Pathol. 2014;36:139-43 pubmed
  111. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed 出版商
  112. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed 出版商
  113. Devi L, Ohno M. PERK mediates eIF2? phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Neurobiol Aging. 2014;35:2272-81 pubmed 出版商
  114. Bellas C, Garcia D, Vicente Y, Kilany L, Abraira V, Navarro B, et al. Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma. PLoS ONE. 2014;9:e98169 pubmed 出版商
  115. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  116. Dadone B, Ambrosetti D, Carpentier X, Duranton Tanneur V, Burel Vandenbos F, Amiel J, et al. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?. Cancer Genet. 2013;206:347-52 pubmed
  117. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed 出版商
  118. Liu H, Zhang W, Jia Y, Yu Q, Grau G, Peng L, et al. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells. Cell Death Dis. 2013;4:e857 pubmed 出版商
  119. Caramuta S, Lee L, Ozata D, Akçakaya P, Georgii Hemming P, Xie H, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3:e152 pubmed 出版商
  120. Tan M, Yu J, Jiang T, Zhu X, Guan H, Tan L. IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice. J Alzheimers Dis. 2014;38:633-46 pubmed 出版商
  121. Wong K, Gascoyne D, Brown P, Soilleux E, Snell C, Chen H, et al. Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. Leukemia. 2014;28:362-72 pubmed 出版商
  122. Devi L, Ohno M. Mechanisms that lessen benefits of ?-secretase reduction in a mouse model of Alzheimer's disease. Transl Psychiatry. 2013;3:e284 pubmed 出版商
  123. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  124. Laarman A, Mijnheer G, Mootz J, van Rooijen W, Ruyken M, Malone C, et al. Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J. 2012;31:3607-19 pubmed 出版商
  125. Farias V, Linares Fernández J, Peñalver J, Payá Colmenero J, Ferrón G, Duran E, et al. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta. 2011;32:86-95 pubmed 出版商
  126. Cheuk W, Tam F, Chan A, Luk I, Yuen A, Chan W, et al. Idiopathic cervical fibrosis--a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol. 2010;34:1678-85 pubmed 出版商
  127. Arber C, Halter J, Stern M, Rovo A, Gratwohl A, Tichelli A. Graft source determines human hematopoietic progenitor distribution pattern within the CD34(+) compartment. Bone Marrow Transplant. 2011;46:650-8 pubmed 出版商
  128. Cheuk W, Chan J, Nuovo G, Chan M, Fok M. Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)?. Int J Surg Pathol. 2007;15:180-6 pubmed